SRSandro R. P. da Rocha

Sandro R. P. da Rocha

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Sandro R. P. da Rocha has a total of 32 co-authors. Here are the top co-authors by number of shared publications:

  • Libo Wu

    Department of Chemical Engineering and Materials Science, College of Engineering, Wayne State University , Detroit, MI

    5 shared publications
  • Balaji Bharatwaj

    Department of Chemical Engineering and Materials Science, and ‡Department of Pharmaceutical Sciences, Wayne State University , Detroit, Michigan 48202, United States

    4 shared publications
  • Lin Yang

    Department of Chemical Engineering and Materials Science, College of Engineering, Wayne State University , 5050 Anthony Wayne Drive, Detroit, Michigan 48202, United States

    3 shared publications
  • Denise S. Conti

    Department of Chemical Engineering and Materials Science, College of Engineering, Wayne State University , 5050 Anthony Wayne Drive, Detroit, Michigan 48202, United States

    2 shared publications
  • Jordan Grashik

    Department of Chemical Engineering and Materials Science, College of Engineering, Wayne State University, 5050 Anthony Wayne Drive, Detroit, Michigan 48202, United States

    2 shared publications
  • Lionel Porcar

    Materials Science and Engineering Department, University of Maryland, College Park, MD 20742, United States

    2 shared publications

Latest Publications

  • Effect of the Conjugation Density of Triphenylphosphonium Cation on the Mitochondrial Targeting of Poly(amidoamine) Dendrimers

    by Elizabeth R. Bielski, Qian Zhong, Matthew Brown, Sandro R. P. da Rocha

    Many clinically relevant diseases with known poor therapeutic outcomes, including cancer and neurodegenerative disorders, have been directly linked to mitochondrial dysfunction. The ability to efficiently target therapeutics to intracellular organelles such as mitochondria may represent new opportunities for the effective treatment of such ailments. The present study reports the synthesis, cellular uptake, cytotoxicity, and mitochondrial colocalization of conjugates of triphenylphosphonium cation (TPP) to amine-terminated, generation 4, poly(amidoamine) (PAMAM) dendrimer (G4NH2) nanocarriers. The mitochondrial-targeting moiety TPP was either directly conjugated to G4NH2 (G4NH2–TPP) or to the dendrimer through a flexible polyethylene glycol (PEG) linker (G4NH2–PEGTPP). Conjugation was done at various TPP densities to assess their biological activity and potential for mitochondrial-targeted drug delivery. Tests in an in vitro model of the human alveolar carcinoma (A549 cells) showed that even at a low TPP density (∼5 TPP) both the cellular internalization and mitochondrial targeting increase significantly, as determined by fluorescence activated cell sorting (FACS) and confocal microscopy (CM), respectively. At a density of ∼10 TPP per G4NH2, further increase in cellular internalization and mitochondrial targeting was achieved. However, at this higher density, the nanocarriers also showed pronounced cytotoxicity. It was observed that the toxicity of the conjugates is decreased upon the addition of a PEG linker between the dendrimer and TPP (G4NH2–PEGTPP), while the mitochondrial targeting ability of the nanocarriers is not affected as the PEG density increases. The proposed strategies indicate that TPP-conjugated G4NH2 dendrimers represent a potentially viable strategy for the targeting of therapeutic molecules to mitochondria, which may help improve therapeutic outcomes of diseases related to mitochondrial dysfunction.


  • Open Access

    Dendrimer Nanocarriers for Transport Modulation Across Models of the Pulmonary Epithelium

    by Balaji Bharatwaj, Abdul Khader Mohammad, Radovan Dimovski, Fernando L. Cassio, Reinaldo C. Bazito, Denise Conti, Qiang Fu, Joshua Reineke, Sandro R. P. da Rocha

    The purpose of this study was to determine the effect of PEGylation on the interaction of poly(amidoamine) (PAMAM) dendrimer nanocarriers (DNCs) with in vitro and in vivo models of the pulmonary epithelium. Generation-3 PAMAM dendrimers with varying surface densities of PEG 1000 Da were synthesized and characterized. The results revealed that the apical to basolateral transport of DNCs across polarized Calu-3 monolayers increases with an increase in PEG surface density. DNC having the greatest number of PEG groups (n = 25) on their surface traversed at a rate 10-fold greater than its non-PEGylated counterpart, in spite of their larger size. This behavior was attributed to a significant reduction in charge density upon PEGylation. We also observed that PEGylation can be used to modulate cellular internalization. The total uptake of PEG-free DNC into polarized Calu-3 monolayers was 12% (w/w) vs 2% (w/w) for that with 25 PEGs. Polarization is also shown to be of great relevance in studying this in vitro model of the lung epithelium. The rate of absorption of DNCs administered to mice lungs increased dramatically when conjugated with 25 PEG groups, thus supporting the in vitro results. The exposure obtained for the DNC with 25PEG was determined to be very high, with peak plasma concentrations reaching 5 μg·mL–1 within 3 h. The combined in vitro and in vivo results shown here demonstrate that PEGylation can be potentially used to modulate the internalization and transport of DNCs across the pulmonary epithelium. Modified dendrimers thereby may serve as a valuable platform that can be tailored to target the lung tissue for treating local diseases, or the circulation, using the lung as pathway to the bloodstream, for systemic delivery.


  • Understanding Solvation in the Low Global Warming Hydrofluoroolefin HFO-1234ze Propellant

    by Lin Yang, Sandro R. P. da Rocha

    Hydrofluoroolefins (HFOs), with zero ozone-depleting effect and very low global warming potential, are considered to be the next-generation high-pressure working fluids. They have industrial relevance in areas including refrigeration and medical aerosols. One major challenge expected in the replacement of existing working fluids with HFOs is the solubility and solvation of additives in such hydrophobic and oleophobic low dielectric semifluorinated solvents. The study of the solvation of chemistries that represent those additives by HFOs is, therefore, of great relevance. In this work, we systematically investigate how the polarity and structure of fragments (the tail, t) that represent those additives affect their binding energy (Eb) with HFO-1234ze (1,1,1,3-tetrafluoropropene) (the solvent, s; Ebst). We also compare and contrast those results with those for the working fluids that are most widely used in the industry, the hydrofluoroalkanes (HFAs) HFA-134a and HFA-227. Three main chemistries were investigated: alkanes, ethers, and esters. It was found that HFO-1234ze interacts quite favorably with ethers and esters, as indicated by their Ebst, while Ebst with alkanes was much lower. While ether and ester groups showed little difference in Ebst, the much lower self-interaction energy between ether tail–tail fragments (Ebtt) is expected to result in improved solubility/solvation of those groups in HFO-1234ze when compared with the more polar ester groups. The ratio Ebst/Ebtt is defined as the enhancement factor (Eenh) and is expected to be a better predictor of solubility/solvation of the tail fragments. The branching of the tail groups upon the addition of pendant CH3 groups did not significantly affect the solvation by the propellant. At low branching density (one CH3 pendant group), it did not affect tail–tail self-interaction either. However, at high enough branching (two CH3 groups), steric hindrance caused a significant decrease in Ebtt and thus an increase in Eenh, suggesting that branching may be used as a strategy to enhance solvation in HFO propellants. Finally, the solvation behavior of HFO-1234ze was found to be similar to that of HFA-134a, thus suggesting similar considerations may apply for both propellants, when solvation properties are of a concern to the application.


  • Open Access

    Poly(amidoamine) Dendrimer Nanocarriers and Their Aerosol Formulations for siRNA Delivery to the Lung Epithelium

    by Denise S. Conti, Daniel Brewer, Jordan Grashik, Sumant Avasarala, Sandro R. P. da Rocha

    Small interfering RNA (siRNA)-based therapies have great promise in the treatment of a number of prevalent pulmonary disorders including lung cancer, asthma and cystic fibrosis. However, progress in this area has been hindered due to the lack of carriers that can efficiently deliver siRNA to lung epithelial cells, and also due to challenges in developing oral inhalation (OI) formulations for the regional administration of siRNA and their carriers to the lungs. In this work we report the ability of generation four, amine-terminated poly(amidoamine) (PAMAM) dendrimer (G4NH2)–siRNA complexes (dendriplexes) to silence the enhanced green fluorescent protein (eGFP) gene on A549 lung alveolar epithelial cells stably expressing eGFP. We also report the formulation of the dendriplexes and their aerosol characteristics in propellant-based portable OI devices. The size and gene silencing ability of the dendriplexes was seen not to be a strong function of the N/P ratio. Silencing efficiencies of up to 40% are reported. Stable dispersions of the dendriplexes encapsulated in mannitol and also in a biodegradable and water-soluble co-oligomer were prepared in hydrofluoroalkane (HFA)-based pressurized metered-dose inhalers (pMDIs). Their aerosol characteristics were very favorable, and conducive to deep lung deposition, with respirable fractions of up to 77%. Importantly, siRNA formulated as dendriplexes in pMDIs was shown to keep its integrity after the particle preparation processes, and also after long-term exposures to HFA. The relevance of this study stems from the fact that this is the first work to report the formulation of inhalable siRNA with aerosol properties suitable to deep lung deposition using pMDIs devices that are the least expensive and most widely used portable inhalers. This study is relevant because, also for the first time, it shows that siRNA–G4NH2 dendriplexes can efficiently target lung alveolar epithelial A549 cells and silence genes even after siRNA has been exposed to the propellant environment.


  • PEGylated, NH2-Terminated PAMAM Dendrimers: A Microscopic View from Atomistic Computer Simulations

    by Lin Yang, Sandro R. P. da Rocha

    Poly(amido amine) (PAMAM) dendrimers are promising nanocarriers in a wide range of biomedical applications including gene and drug delivery and as imaging agents. They have unique structural properties and are characterized by high size uniformity, low polydispersity, and a large number of modifiable surface groups. Drug–dendrimer systems are usually further modified through the conjugation of ligands in order to confer the carriers’ specific characteristics designed to enhance their efficacy. The chemistry and structure of the solvated ligand-conjugated dendrimer nanocarriers (DNCs) will dictate how they interact with the physiological environment and, therefore, their fate and function. Understanding the microstructures of ligand-conjugated DNCs is, therefore, of great relevance within the context of drug delivery applications. In this work, we investigate the effect of poly(ethylene glycol) (PEG) on the microstructure of solvated, NH2-terminated PAMAM DNCs using fully atomistic molecular dynamics simulations. Several variables including dendrimer generation (2–5), PEGylation density (0–50%), and PEG Mw (500 and 1000) were investigated. The results obtained showed a good match with available experimental results, including size as a function of dendrimer degeneration (G2NH2–G5NH2). No back-folding is observed for PAMAM dendrimers with generation lower than G5NH2. G2NH2 and G3NH2 showed a dense-packed, nonglobular structure, and G4NH2 and G5NH2 have a segmented, “open” structure. Our results help settle a long-standing debate with respect to “back-folding” as the microstructural information obtained here is reconciled with experimental results. PEGylation was found to influence the microstructure in a different way, including an expected increase in the overall size of the DNCs, while not affecting much the solvation of unmodified terminal (primary) amines. It also serves to expand the core of dendrimers, reduce the surface charge, and change solvation behavior of different generation branching amines. We show that the microstructure of a PEG layer with the same number of repeat units can be significantly altered by changing the grafting density and size of PEG. Potential consequences in the design of PEGylated dendrimers for drug delivery and targeting are discussed based on the obtained microstructural information.


  • Polymeric Nanocarriers for Transport Modulation across the Pulmonary Epithelium: Dendrimers, Polymeric Nanoparticles, and their Nanoblends

    by Balaji Bharatwaj, Radovan Dimovski, Denise S. Conti, Sandro R. P. da Rocha

    The purpose of this study was to (a) Determine the cellular transport and uptake of amine-terminated generation 3 (G3) poly(amido amine) (PAMAM) dendrimers across an in vitro model of the pulmonary epithelium, and the ability to modulate their transport by forming nanoblends of the dendrimers with biodegradable solid polymeric nanoparticles (NPs) and (b) to formulate dendrimer nanocarriers in portable oral inhalation devices and evaluate their aerosol characteristics. To that end, fluorescein isothiocyanate (FITC)-labeled G3 PAMAM dendrimer nanocarriers (DNCs) were synthesized, and also encapsulated within poly lactide-co-glycolide nanoparticles (NPs). Transport and uptake of both DNCs encapsulated within NPs (nanoblends) and unencapsulated DNCs were tracked across polarized monolayers of airway epithelial cells, Calu-3. DNCs were also formulated as core-shell microparticles in pressurized metered-dose inhalers (pMDIs) and their aerodynamic properties evaluated by Andersen cascade impaction. The apparent permeability of DNCs across the airway epithelial model was similar to that of a paracellular marker of comparable molar mass—order of 10−7 cm s−1. The transport and cellular internalization of the DNCs can be modulated by formulating them as nanoblends. The transport of the DNCs across the lung epithelium was completely suppressed within the time of the experiment (5 h) when formulated as blends. The encapsulation also prevents saturation of the cellular internalization profile. Nanoblending may be a potential strategy to modulate the rate of transport and cellular uptake of DNCs, and thus be used as a design strategy to achieve enhanced local or systemic drug delivery.


  • Solvation in hydrofluoroalkanes: how can ethanol help?

    by Denise S. Conti, Jordan Grashik, Lin Yang, Libo Wu, Sandro R. P. da Rocha

    Objectives The goal of this work was to evaluate the ability of ethanol mixed with hydrofluoroalkanes (HFAs) to improve solvation of moieties of relevance to pressurized metered‐dose inhalers (pMDIs). Methods Chemical force microscopy was used to measure the adhesion force (Fad) between alkyl‐based, ether‐based and ester‐based moieties (C8/C8, COC/COC and COOC/COOC interactions) in 2H,3H‐perfluoropentane (HPFP)/ethanol mixtures. HPFP is a liquid that mimics propellant HFAs. The Fad results are thus a measure of solvation in HFAs. Johnson–Kendall–Roberts (JKR) theory was used to model the results. Key findings The Fad normalized by the tip radius of curvature (Fad/R) decreased upon the addition of ethanol, suggesting its ability to enhance the solvent environment. At 15% (v/v) ethanol, the Fad/R was reduced 34% for the alkyl, 63% for the ether, and down 67% for the ester tails. Thus, the solvation could be ranked as: ester > ether > alkyl. JKR theory was a reasonable model for the Fad/R. Conclusions Ethanol, within the concentration range of interest in commercial pMDIs, provided limited enhancement in solvation of alkyl moieties. On the other hand, the cosolvent significantly enhanced solvation of ether‐based and ester‐based moieties, thus suggesting its potential for formulations containing amphiphiles with such groups.


  • Science and Technology of Pressurized Metered-Dose Inhalers

    by Sandro R. P. da Rocha, Balaji Bharatwaj, Sowmya Saiprasad


  • Nanocapsules by Miniemulsion Polymerization with Biodegradable Surfactant and Hydrophobe

    by Ana P. Romio, Claudia Sayer, Pedro H. H. Araújo, Mariam Al-Haydari, Libo Wu, Sandro R. P. da Rocha